Optimizing Treatment Outcomes in Retinal Vein Occlusion : Episode 1

Opinion

Video

August 14, 2024

Optimizing Treatment Outcomes in Retinal Vein Occlusion (RVO)

Author(s):

Hong-Uyen Hua, MD,Sruthi Arepalli, MD

A panel of ophthalmologists discuss strategies for improving patient outcomes in retinal vein occlusion with anti-VEGF and other therapies.

EP: 1.Optimizing Treatment Outcomes in Retinal Vein Occlusion (RVO)

0:50 RVO Challenges

2:30 Treatment Selection

8:00 Diagnostics

10:50 Role of Ang-2 in RVO

13:50 Steroids in RVO

18:00 Patient Education

Related Videos

Quan Dong Nguyen, MD: Phase 2 Neptune Trial Advances Brepocitnib for Uveitis | Image Credit: Stanford University

Charles C. Wykoff, MD, PhD: Phase 1b/2a Results on Restoret for DME, nAMD | Image Credit: Retina Consultants of Texas

Christine N. Kay, MD | Image Credit: Atsena Therapeutics

Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates

Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital

Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates

Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates

Joel A. Pearlman, MD, PhD: Phase 2a Data on Oral RZ402 for DME | Image Credit: Retina Consultants Medical Group

Roger A. Goldberg, MD: Pooled Visual Function Data of NT-501 for MacTel | Image Credit: Bay Area Retina Associates

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.